West to Showcase New Extensions of the SmartDose® Drug Delivery Platform at the PDA Universe of Pre-filled Syringes and Injection Devices
"Advancements in drug development need to be paired with advances in drug delivery, such as last year's
West's SmartDose drug delivery platform allows patients to self-administer medication in accordance with their prescribed treatment. West developed this wearable device with extensive human factors testing and analysis to understand the interaction between the patient and the delivery system. All versions of the SmartDose platform adhere to the patient's body, usually on the abdomen, so patients can be hands free during administration. The SmartDose platform offers a variety of integrated solutions for delivery and containment featuring a silicone-free Daikyo Crystal Zenith® cartridge and a FluroTec® coated piston containment system. West has built upon the success of the Generation I (Gen. I) device to address market needs for higher-dose volumes and enhanced functionality and usability and now offers for development:
- SmartDose Gen. II device, a system that can accommodate injection volumes of up to 10 mL, as well as both glass and Daikyo Crystal Zenith containers.
- SmartDose Gen. III device, a preloaded version, that reduces user steps and simplifies supply chain.
Both versions will be featured at the conference.
West will participate in the following educational sessions at the PDA Universe of Pre-filled Syringes and Injection Devices:
- Pre-conference workshops
November 6, 3:00 p.m.– "Why Make Your Existing Auto-injector 'Smart': Comparison and Benefits of Different Accessory Form Factors and Integration into a Connected Health Platform," Brian Lynch, Senior Director, Innovation at West November 6, 3:15 p.m.– "West's SmartDose Platform: A Wearable Engineered with Both Patient & Pharma Partner in Mind," Nico Brandes, Director, Market Development, I&T at West November 6, 3:30 p.m.– "Particulates in Sterile Drug Products: Testing and Contributions from Packaging Components," Fran DeGrazio, Vice President of Scientific Affairs & Technical Services at West
- Scientific program sessions
November 7, 2:25 p.m.– "Advances in Intradermal Drug Delivery: From Vaccines to Immunotherapy and Beyond," Yotam Levin, Chief Executive Officer at NanoPassTM Technologies Ltd., a strategic partner of West November 7, 4:55 p.m.– "The Changing Diabetes Landscape: Linking Diagnostics with Injection," Aileen Kinsella, Director of Segment Marketing at West November 8, 7:30 a.m.– "PDA Interest Group Meeting: Packaging Science," moderated by Bettine Boltres, Manager, Technical Customer Services at West, and Derek Duncan, Vice President of Marketing at Lighthouse Instruments November 8, 9:00 a.m.– "Clinical Needs: Patient-Device Interface," moderated by Mike Schaefers, Vice President and General Manager, Global Pharma at West
- Post-conference workshops
Christa Jansen-Otten, Director, Global Product Management, Prefilled Systems & Delivery at West, will lead two sessions in the workshop, "Development and Manufacturing of Pre-filled Syringes: A Hands-on Training": November 9, 9:05 a.m.– "Advantages of Pre-filled Syringe and Market Trends in Primary Packaging" November 10, 11:00 a.m.– "Elastomeric Closures for Pre-filled Syringes and Cartridges"
Additionally, West will present three scientific posters, which will be available in the Exhibit Hall during the conference:
- "Determination of
Piston Movementin Low Pressure/High Altitude Conditions in Daikyo Crystal Zenith Containers," Rohit Vora, Engineer, Container Systems, R&D at West
- "PFS Plunger Evaluations in Different Auto-injection Modes,"
Fran DeGrazio, Vice President of Scientific Affairs & Technical Services at West
- "Risk-Based Approach to Achieving 'Zero-Defect' Products for Personalized Medicine Applications," John Dinka, Senior Director, Pharmaceutical Processing, R&D at West
For more information on West products and services, please visit booth X67 at PDA Universe of Pre-filled Syringes and Injection Devices or visit us online at www.westpharma.com.
Certain forward-looking statements are included in this release. These statements reflect management's current expectations regarding future events and operating performance and speak only as of the date of this release. There is no certainty that West's SmartDose® drug delivery platform, or any other products, will achieve any level of commercial success. These forward-looking statements involve a number of risks and uncertainties. For a description of certain additional factors that could cause West's future results to differ from those expressed in any such forward-looking statements, see Item 1A, entitled "Risk Factors," in West's Annual Report on Form 10-K for the year ended
West and the diamond logo and FluroTec are trademarks or registered trademarks of
SmartDose® is a registered trademark of
Daikyo Crystal Zenith® is a registered trademark of
NanoPass is a trademark of NanoPass
View original content with multimedia:http://www.prnewswire.com/news-releases/west-to-showcase-new-extensions-of-the-smartdose-drug-delivery-platform-at-the-pda-universe-of-pre-filled-syringes-and-injection-devices-300549621.html